Apogee Therapeutics, Inc. Restricted Cash
Apogee Therapeutics, Inc. (APGE) had Restricted Cash of $0 as of 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Balance Sheet › Assets
us-gaap:RestrictedCash · last filed 2026-03-02
- 2025-12-31: Restricted Cash $0.00.
- 2025-09-30: Restricted Cash $0.00.
- 2025-06-30: Restricted Cash $300.00K.
- 2025-03-31: Restricted Cash $300.00K.
| Period end | Restricted Cash |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-02 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-10 |
| 2025-06-30 | $300.00K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $300.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $300.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | $300.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $300.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $300.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $300.00K 10-K · filed 2025-03-03 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-05 |